These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9764553)

  • 1. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
    Karthaus M; Wolf HH; Kämpfe D; Egerer G; Ritter J; Peters G; Südhoff T; Franke A; Heil G; Kullmann KH; Jürgens H
    Chemotherapy; 1998; 44(5):343-54. PubMed ID: 9732151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
    Petrilli AS; Dantas LS; Campos MC; Tanaka C; Ginani VC; Seber A
    Med Pediatr Oncol; 2000 Feb; 34(2):87-91. PubMed ID: 10657866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Jürgens H
    Antibiot Chemother (1971); 2000; 50():47-58. PubMed ID: 10874454
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of febrile neutropenia episodes in systemic hematologic illnesses with new once daily ceftriaxone administration].
    Karthaus M; Südhoff T; Fenchel K; Egerer G; Kämpfe D; Ritter J; Franke A; Heil G; Peters G; Jürgens H
    Wien Med Wochenschr; 1998; 148(21):481-7. PubMed ID: 10048176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.
    Tomlinson RJ; Ronghe M; Goodbourne C; Price C; Lilleyman JS; Das S; Saha V
    Arch Dis Child; 1999 Feb; 80(2):125-31. PubMed ID: 10325726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.
    Charnas R; Lüthi AR; Ruch W
    Pediatr Infect Dis J; 1997 Apr; 16(4):346-53. PubMed ID: 9109134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
    Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone versus beta-lactams with antipseudomonal activity for empirical, combined antibiotic therapy in febrile neutropenia: a meta-analysis.
    Furno P; Dionisi MS; Bucaneve G; Menichetti F; Del Favero A
    Support Care Cancer; 2000 Jul; 8(4):293-301. PubMed ID: 10923769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
    Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care.
    Egerer G; Goldschmidt H; Müller I; Karthaus M; Günther H; Ho AD
    Chemotherapy; 2001; 47(3):219-25. PubMed ID: 11306792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
    Cornely OA; Salzberger B; Bethe U; Seifert H; Fätkenheuer G; Diehl V; Schrappe M
    Antibiot Chemother (1971); 2000; 50():37-46. PubMed ID: 10874453
    [No Abstract]   [Full Text] [Related]  

  • 17. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents.
    Sahu S; Bapna A; Pai SK; Nair CN; Kurkure PA; Advani SH
    Pediatr Hematol Oncol; 1997; 14(3):205-11. PubMed ID: 9185205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.
    Chuang YY; Hung IJ; Yang CP; Jaing TH; Lin TY; Huang YC
    Pediatr Infect Dis J; 2002 Mar; 21(3):203-9. PubMed ID: 12005083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory treatment with ceftriaxone in febrile neutropenic children.
    Kaplinsky C; Drucker M; Goshen J; Tamary H; Cohen IJ; Zaizov R
    Isr J Med Sci; 1994 Aug; 30(8):649-51. PubMed ID: 8045751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.